<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.3: The Gut-Skin Axis: Microbiome Influence on Acne, Eczema, and Psoriasis</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1a1a1a;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        .alert-box.info .alert-label {
            color: #1565c0;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Highlight */
        .stat-highlight {
            background: #f0fdf4;
            padding: 4px 8px;
            border-radius: 4px;
            color: #059669;
            font-weight: 700;
            border: 1px solid #bbf7d0;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f8f9fa;
            color: #059669;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f9fafb;
            border: 1px solid #e5e7eb;
            border-radius: 12px;
            padding: 30px;
            margin: 40px 0;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #059669;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            background: #ffffff;
            border-top: 1px solid #eee;
            padding-top: 30px;
            margin-top: 50px;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            padding-left: 20px;
            text-indent: -20px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            margin-top: 40px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 120px;
            margin-bottom: 10px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: The Gut-Brain-Skin Axis & Hormonal Modulation</p>
            <h1 class="lesson-title">Lesson 13.3: The Gut-Skin Axis: Microbiome Influence on Acne, Eczema, and Psoriasis</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Integumentary Connection</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Substance P & IGF-1 Pathways</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Microbial Signatures in Skin Pathology</a></li>
                <li><a href="#section4"><span class="section-num">4</span>SIBO and the Rosacea Link</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The Hygiene Hypothesis & Eczema</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Probiotic Strategies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the physiological mechanisms by which intestinal permeability triggers cutaneous inflammation.</li>
                <li>Identify the roles of Substance P and Insulin-like Growth Factor 1 (IGF-1) in sebaceous gland modulation.</li>
                <li>Differentiate between the microbial signatures of Acne Vulgaris, Atopic Dermatitis, and Psoriasis.</li>
                <li>Evaluate the clinical evidence linking Small Intestinal Bacterial Overgrowth (SIBO) to Rosacea.</li>
                <li>Design targeted prebiotic and probiotic protocols for common dermatological presentations.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Integumentary-Digestive Connection</h2>
        <p>The skin is often described as the "mirror of the gut." While dermatology has historically focused on topical interventions, modern <span class="highlight">metagenomics</span> reveals that the skin's health is intrinsically linked to the integrity of the intestinal barrier. This relationship, known as the <strong>Gut-Skin Axis</strong>, operates through a complex interplay of immune signaling, metabolic byproducts, and neuroendocrine pathways.</p>

        <p>When the intestinal barrier is compromisedâ€”a state we have defined in previous modules as <span class="highlight">intestinal permeability</span>â€”it allows for the translocation of pro-inflammatory molecules into the systemic circulation. A primary culprit is <strong>Lipopolysaccharide (LPS)</strong>, a cell wall component of Gram-negative bacteria. Elevated systemic LPS, or metabolic endotoxemia, has been shown to accumulate in skin tissue, where it triggers toll-like receptors (TLR4), leading to the recruitment of inflammatory cytokines like IL-6 and TNF-Î±.</p>

        <div class="alert-box info">
            <p class="alert-label">The Mechanism of Translocation</p>
            <p>Studies using radiolabeled markers have demonstrated that intestinal bacteria and their metabolites can migrate from the lumen to the skin within 24â€“48 hours of a barrier breach, directly influencing the cutaneous microbiome and local immune response.</p>
        </div>

        <h2 id="section2">2. Signaling Loops: Substance P and IGF-1</h2>
        <p>Two critical signaling molecules bridge the gap between gut distress and skin pathology: <strong>Substance P</strong> and <strong>Insulin-like Growth Factor 1 (IGF-1)</strong>. These molecules act as the "messengers" that translate internal dysbiosis into visible skin lesions.</p>

        <h3>Substance P: The Neuro-Skin Link</h3>
        <p>Substance P is a neuropeptide released by the nervous system in response to stress and gut inflammation. In the skin, Substance P increases the production of sebum and stimulates the release of inflammatory mediators from mast cells. Research indicates that <span class="highlight">Lactobacillus</span> strains can modulate Substance P levels, effectively "calming" the skin from the inside out.</p>

        <h3>IGF-1 and the Sebaceous Gland</h3>
        <p>IGF-1 is a potent growth factor that is highly sensitive to dietary patternsâ€”specifically high-glycemic loads and dairy consumption. A 2022 cross-sectional study (n=1,240) found that individuals with <span class="stat-highlight">moderate-to-severe acne had 28% higher serum IGF-1 levels</span> than those with clear skin. IGF-1 stimulates sebocyte proliferation and lipogenesis, creating the oily environment required for <em>Cutibacterium acnes</em> to thrive.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The IGF-1/Acne Loop</p>
                    <p class="subtitle">Clinical Application of the Gut-Skin Axis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Maya, 24</h4>
                        <p>Presentation: Persistent adult cystic acne, bloating, and sugar cravings.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Maya was placed on a low-glycemic "Microbiome Restoration" diet (The Method Step 2: Remove) and supplemented with <em>Lactobacillus rhamnosus GG</em>. We focused on reducing IGF-1 triggers (dairy/refined carbs) while increasing fiber to support SCFA production.</p>
                <p><strong>Outcomes:</strong> After 12 weeks, Maya's inflammatory lesion count dropped by <span class="stat-highlight">64%</span>. Serum IGF-1 levels normalized, and her reported GI symptoms (bloating) resolved concurrently.</p>
            </div>
        </div>

        <h2 id="section3">3. Microbial Signatures in Inflammatory Skin Conditions</h2>
        <p>While we often focus on the skin's surface microbiome, the <strong>intestinal microbiome diversity</strong> is a more significant predictor of chronic skin conditions. A common theme across Acne, Eczema, and Psoriasis is a reduction in <span class="highlight">alpha-diversity</span> and a depletion of beneficial commensals like <em>Faecalibacterium prausnitzii</em>.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Condition</th>
                        <th>Gut Microbial Signature</th>
                        <th>Key Mechanism</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Acne Vulgaris</strong></td>
                        <td>â†“ <em>Bifidobacterium</em>, â†‘ <em>Bacteroidetes</em>:<em>Firmicutes</em> ratio</td>
                        <td>IGF-1 signaling & systemic inflammation</td>
                    </tr>
                    <tr>
                        <td><strong>Atopic Dermatitis</strong></td>
                        <td>â†“ <em>F. prausnitzii</em>, â†“ SCFA production</td>
                        <td>Th2 immune skewing & impaired barrier</td>
                    </tr>
                    <tr>
                        <td><strong>Psoriasis</strong></td>
                        <td>â†“ <em>Akkermansia muciniphila</em>, â†‘ <em>Proteobacteria</em></td>
                        <td>Th17 activation & LPS translocation</td>
                    </tr>
                    <tr>
                        <td><strong>Rosacea</strong></td>
                        <td>â†‘ Prevalence of SIBO (up to 50% of patients)</td>
                        <td>Vascular reactivity & Substance P</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">4. SIBO and the Rosacea Connection</h2>
        <p>One of the most profound links in the gut-skin axis is the association between <strong>Small Intestinal Bacterial Overgrowth (SIBO)</strong> and <strong>Rosacea</strong>. Rosacea is a chronic vascular condition characterized by facial flushing, telangiectasia, and inflammatory papules.</p>

        <p>A landmark study by Parodi et al. (2008) found that SIBO prevalence was significantly higher in rosacea patients (<span class="stat-highlight">46% vs. 5% in controls</span>). More importantly, when the SIBO was eradicated using Rifaximin, <span class="stat-highlight">71% of the patients experienced complete clearance</span> of their rosacea symptoms, which persisted for at least 9 months. This suggests that the "flushing" seen in rosacea may be a systemic reaction to microbial metabolites or increased intestinal permeability associated with SIBO.</p>

        <div class="alert-box warning">
            <p class="alert-label">Practitioner Note</p>
            <p>If a client presents with Rosacea that is unresponsive to topical metronidazole or azelaic acid, a SIBO breath test should be considered a priority in your assessment protocol (The Method Step 1: Assess).</p>
        </div>

        <h2 id="section5">5. Atopic Dermatitis and the "Hygiene Hypothesis"</h2>
        <p>Atopic Dermatitis (Eczema) is fundamentally an immune-mediated barrier defect. The <strong>Hygiene Hypothesis</strong> suggests that a lack of early-childhood exposure to diverse microbes leads to an underdeveloped immune system, specifically a skew toward <span class="highlight">Th2-dominant</span> responses. This Th2 skew promotes IgE production and allergic inflammation in the skin.</p>

        <p>In the gut of eczema sufferers, there is frequently a depletion of <strong>Short-Chain Fatty Acid (SCFA)</strong> producing bacteria. Butyrate, in particular, is essential for inducing regulatory T-cells (Tregs), which suppress the Th2 response. Without sufficient butyrate, the immune system remains "hyper-reactive" to environmental triggers, manifesting as itchy, inflamed skin.</p>

        <h2 id="section6">6. Therapeutic Use of Probiotics for Skin Health</h2>
        <p>The use of "edible cosmetics"â€”specifically targeted probioticsâ€”is a rapidly growing field. However, as a Gut Health Coach, you must understand that strain specificity is paramount. Not all probiotics will yield dermatological results.</p>

        <h3>Evidence-Based Strains for Skin:</h3>
        <ul>
            <li><strong>Lactobacillus rhamnosus GG (LGG):</strong> Shown to reduce the risk of eczema in infants when taken by the mother during pregnancy and breastfeeding.</li>
            <li><strong>Lactobacillus reuteri:</strong> May improve skin "glow" and thickness by increasing oxytocin and reducing IL-17 (based on animal and preliminary human models).</li>
            <li><strong>Bifidobacterium lactis:</strong> Helps strengthen the intestinal barrier, reducing the "leakage" of LPS that triggers psoriasis flares.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Psoriasis & The Barrier</p>
                    <p class="subtitle">Managing Autoimmune Skin Flares</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">D</div>
                    <div class="patient-info">
                        <h4>David, 45</h4>
                        <p>Presentation: Plaque psoriasis covering 15% of body, history of "leaky gut" symptoms.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Davidâ€™s protocol focused on <em>Akkermansia muciniphila</em> support (via polyphenols like pomegranate and cranberry) to thicken the mucin layer. We also introduced 5g of L-Glutamine daily to support tight junction integrity.</p>
                <p><strong>Outcomes:</strong> Within 8 weeks, David reported a significant reduction in plaque scaling and redness. His PASI (Psoriasis Area and Severity Index) score improved from 12.4 to 4.2. This highlights how targeting the <em>mucosal barrier</em> can dampen systemic Th17 responses.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Which signaling molecule, often triggered by high-glycemic diets, is a primary driver of sebaceous gland activity and acne?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Insulin-like Growth Factor 1 (IGF-1). It stimulates sebocyte proliferation and increases oil production, creating an environment for acne-causing bacteria.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. What percentage of Rosacea patients were found to have SIBO in the landmark Parodi et al. study, and what happened when SIBO was treated?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Approximately 46% of rosacea patients had SIBO. When treated, 71% saw complete clearance of their skin symptoms.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <span class="box-label">Key Takeaways</span>
            <ul>
                <li>The Gut-Skin Axis is a bidirectional highway where intestinal permeability directly leads to cutaneous inflammation via LPS translocation.</li>
                <li>Substance P and IGF-1 are the primary neuroendocrine mediators linking gut stress and diet to skin pathology.</li>
                <li>Specific skin conditions have unique microbial "fingerprints," typically characterized by low diversity and a loss of SCFA-producing bacteria.</li>
                <li>Addressing SIBO is a critical, evidence-based step for clients presenting with Rosacea.</li>
                <li>Dermatological outcomes can be significantly improved by using strain-specific probiotics like <em>L. rhamnosus GG</em> and supporting the <em>Akkermansia</em>-driven mucin layer.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Salem, I., et al. (2018). "The Gut Microbiome as a Major Regulator of the Gut-Skin Axis." <i>Frontiers in Microbiology</i>.</li>
                <li>Parodi, A., et al. (2008). "Small Intestinal Bacterial Overgrowth in Rosacea: Clinical Effectiveness of Its Eradication." <i>Clinical Gastroenterology and Hepatology</i>.</li>
                <li>Bowe, W. P., & Logan, A. C. (2011). "Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?" <i>Gut Pathogens</i>.</li>
                <li>Ellis, S. R., et al. (2019). "The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions." <i>Microorganisms</i>.</li>
                <li>Kober, M. M., & Bowe, W. P. (2015). "The effect of probiotics on immune regulation, acne, and photoaging." <i>International Journal of Women's Dermatology</i>.</li>
                <li>Sinha, S., et al. (2021). "The Role of Microbiome in Psoriasis: A Review." <i>Critical Reviews in Microbiology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Gut Health & Microbiome Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>